MediPharm Labs Corp. (LABS) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Medipharm Labs Corp..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.149 -- 00:00:01.917 Ladies and gentlemen, this is the operator. 00:00:01.917 -- 00:00:04.610 Today's conference is scheduled to begin momentarily. 00:00:04.610 -- 00:00:07.443 Until that time, your lines will again be placed on music hold. 00:00:07.443 -- 00:00:10.006 Thank you for your patience. 00:01:09.185 -- 00:01:11.185 Thank 00:01:11.568 -- 00:01:15.752 you for standing by, and welcome to the MediPharm Labs conference call to discuss this 00:01:15.752 -- 00:01:19.316 third quarter 2025 results. 00:01:19.316 -- 00:01:24.843 Our speakers on today's call are David Pittock, President and Chief Executive Officer, 00:01:24.843 -- 00:01:27.486 and Craig Hunter, Chief Financial Officer. 00:01:27.486 -- 00:01:32.732 As a reminder, all participants are in listen-only mode, and the conference 00:01:32.732 -- 00:01:37.817 is being recorded. After management's presentation, we will take questions from the analyst 00:01:37.817 -- 00:01:42.500 community on the telephone and then take written questions through the Q&A feature on 00:01:42.500 -- 00:01:44.383 the webcast. 00:01:44.383 -- 00:01:49.109 The information during this call should be considered together with the more detailed 00:01:49.109 -- 00:01:54.617 information, disclosure, financial data, and statements available on the company's website 00:01:54.617 -- 00:02:00.042 and on its CDAR profile at cdarplus.ca. 00:02:00.665 -- 00:02:05.072 As set out on the webcast slide, I would like to note that remarks during this earnings 00:02:05.072 -- 00:02:09.898 call may contain forward-looking information and forward-looking statements within the 00:02:09.898 -- 00:02:15.265 meaning of applicable security laws. This includes, without limitation, 00:02:15.265 -- 00:02:20.612 statements about MediPharm Labs and i...